Streetbeat News

Stock Prices

REGN

Regeneron Pharmaceuticals (NASDAQ:REGN) has received a mix of bullish and indifferent ratings from analysts in the last quarter. The average 12-month price target for the company, according to 13 analysts, is $887.92, with a high of $1050.00 and a low of $811.00. This average price target has increased by 1.69% over the past month.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 6:01 pm

MODV

In the last quarter, 4 analysts have given somewhat bullish ratings for ModivCare (NASDAQ:MODV) with no bearish or indifferent ratings. The average 12-month price target for the company is $94.25, a decrease of 34.55% from the previous average of $144.00.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 6:01 pm

JCI

Johnson Controls Intl (NYSE:JCI) has outperformed the market over the past 5 years, producing an average annual return of 14.99%. An investment of $1000 in JCI stock 5 years ago would be worth $2,003.14 today. The company currently has a market capitalization of $45.97 billion.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 6:00 pm

EWTX

Edgewise Therapeutics (NASDAQ:EWTX) has received positive analyst ratings in the last quarter, with 4 bullish ratings and no bearish or indifferent ratings. The company's average 12-month price target is $25.25, which has increased by 1.0% over the past month.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 6:00 pm

INFY

Infosys (NYSE:INFY) has outperformed the market over the past 10 years, producing an average annual return of 11.89%. If an investor had bought $1000 of INFY stock 10 years ago, it would be worth $3,036.80 today.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 6:00 pm

EW

Edwards Lifesciences (NYSE:EW) has received mostly bullish ratings from 15 analysts over the last quarter, with an average price target of $95.8, implying an upside from the current price of $90.19. The average price target has increased by 7.74% over the past month.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 6:00 pm

FTAI

Analysts have provided bullish ratings for FTAI Aviation (NASDAQ:FTAI) within the last quarter, with an average price target of $37.22, an increase of 25.11% from the previous average price target of $29.75. The ratings are based on the company's predicted future earnings and the predictability of its revenue streams.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 6:00 pm

VKTX

Viking Therapeutics (NASDAQ:VKTX) has received positive analyst ratings in the last quarter, with 7 bullish and 4 somewhat bullish ratings. The average price target for the stock is $33.36, a significant increase from the current price of $14.4966. This average has increased by 19.14% from the previous average price target of $28.00.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 6:00 pm

ACET

BDTX

CNTG

RIDE

SYTA

TIVC

WBA

Several stocks experienced significant movement in Tuesday's mid-day session. Notable gainers included Tivic Health Systems, Black Diamond Therapeutics, and Centogene, which saw increases due to distribution agreements, promising clinical data, and joint ventures respectively. On the other hand, Adicet Bio, Siyata Mobile, and Lordstown Motors Corp were among the biggest losers, with drops due to disappointing clinical data, share offerings, and bankruptcy filings respectively. Walgreens Boots Alliance also saw a decrease after lowering its FY23 guidance.

Portfolio Pulse from Lisa Levin

June 27, 2023 | 5:56 pm

XPEV

Shares of XPeng Inc - ADR (NYSE:XPEV) are trading higher by 5.60% to $10.75 during Tuesday's session. This is following Chinese Premier Li Qiang's announcement that China is on track to reach its 5% annual growth target and plans to stimulate markets and open select sectors of its economy to international participation. Li also assured the government's continued support for the presence of foreign companies and addressed concerns regarding new data management regulations.

Portfolio Pulse from Henry Khederian

June 27, 2023 | 5:55 pm